Human Papillomavirus (HPV) Pseudovirus Development & Production
Immunogenicity evaluation is an important part of clinical research on HPV preventive vaccines. In WHO guidelines, it is recommended neutralizing antibody levels as an indicator of vaccine protection. The standard methods of titrating anti-HPV activity are essential for the antibody, drug, and vaccine development, such as direct ELISA, single-epitope competition ELISA and pseudovirus neutralization method. Website URL: https://antiviral.creative-diagnostics.com/human-papillomavirus-hpv-pseudovirus-development-production.html